Lineage Cell Therapeutics In shares owned by Nuveen Asset Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Nuveen Asset Management
from 13F filings
Historical chart of Nuveen Asset Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Lineage Cell Therapeutics In by Nuveen Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $763k | 515k | 1.48 |
2023-09-30 | $608k | 515k | 1.18 |
2023-06-30 | $727k | 515k | 1.41 |
2022-03-31 | $750k | 552k | 1.36 |
2021-12-31 | $745k | 407k | 1.83 |
2021-09-30 | $1.1M | 442k | 2.55 |
2021-06-30 | $1.3M | 450k | 2.85 |
2020-03-31 | $349k | 423k | 0.83 |
2019-12-31 | $436k | 490k | 0.89 |
2019-09-30 | $1.0M | 1.1M | 0.98 |